American Association for the Advancement of Science, Science Translational Medicine, 542(12), 2020
DOI: 10.1126/scitranslmed.aay8314
Full text: Unavailable
DMPS, a drug licensed to treat mercury poisoning, is preclinically effective as an oral therapeutic for treating certain hemotoxic snakebites.